Skip to main content

Biomedical Big Data: Opportunities and Challenges (Overview)

  • Chapter
  • First Online:
Clinical Applications of Artificial Intelligence in Real-World Data

Abstract

Artificial Intelligence (AI) in medicine stands at the cusp of revolutionizing clinician reasoning and decision-making. Since its foundational years in the mid-20th century, the progression of medical AI has seen considerable advancements, concurrently grappling with various challenges. Early attempts of AI showcased immense potential, yet faced hurdles from data integration to machine-driven clinical decisions. Modern deep learning neural networks, particularly in image analysis, represent promising advancements. Ensuring the trustworthiness of AI systems is paramount for stakeholders to fully embrace its potential in healthcare. To safeguard patient care and guarantee effective outcomes, a rigorous evaluation of AI applications is essential before wide-scale adoption. This textbook illuminates the multifaceted journey of AI in healthcare, emphasizing its challenges, opportunities, and the pressing need for a rigorous, informed evaluation to ensure AI’s responsible and impactful integration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abràmoff MD, Lou Y, Erginay A, Clarida W, Amelon R, Folk JC, Niemeijer M. Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning. Invest Ophthalmol Vis Sci. 2016;57(13):5200–6.

    Article  Google Scholar 

  2. Collins GS, Dhiman P, Andaur Navarro CL, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 2021;11:e048008.

    Google Scholar 

  3. Ferrucci DA, Brown EW, Chu-Carroll J, Fan J, Gondek D, Kalyanpur A, Lally A, Murdock JW, Nyberg E, Prager JM, Schlaefer N, Welty CA. Building Watson: an overview of the DeepQA project. AI Mag. 2010;31:59–79.

    Google Scholar 

  4. Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, Ting DSW. Artificial intelligence for diabetic retinopathy screening: a review. Eye (Lond). 2020;34(3):451–60.

    Article  Google Scholar 

  5. Kotecha D, Asselbergs FW, Achenbach S, et al. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research. BMJ. 2022;29(378): e069048.

    Article  Google Scholar 

  6. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436.

    Article  Google Scholar 

  7. Liu X, Rivera SC, Moher D, Calvert MJ, Denniston AK. SPIRIT-AI and CONSORT-AI working group. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension. BMJ. 2020;370:m3164.

    Google Scholar 

  8. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447–53.

    Article  Google Scholar 

  9. Shortliffe EH, Axline SG, Buchanan BG, Merigan TC, Cohen SN. An artificial intelligence program to advise physicians regarding antimicrobial therapy. Comput Biomed Res. 1973;6(6):544–60.

    Article  Google Scholar 

  10. Strickland EK. IBM Watson, heal thyself: how IBM overpromised and underdelivered on AI health care IEEE Spectrum 2019;56:24–31.

    Google Scholar 

  11. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56.

    Article  Google Scholar 

  12. Wu E, Wu K, Daneshjou R, et al. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat Med. 2021;27:582–4.

    Article  Google Scholar 

  13. Yu VL, Fagan LM, Wraith SM, Clancey WJ, Scott AC, Hannigan J, Blum RL, Buchanan BG, Cohen SN. Antimicrobial selection by a computer. A blinded evaluation by infectious diseases experts. JAMA. 1979;242(12):1279–82.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Folkert W. Asselbergs .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Asselbergs, F.W., Denaxas, S., Moore, J.H. (2023). Biomedical Big Data: Opportunities and Challenges (Overview). In: Asselbergs, F.W., Denaxas, S., Oberski, D.L., Moore, J.H. (eds) Clinical Applications of Artificial Intelligence in Real-World Data. Springer, Cham. https://doi.org/10.1007/978-3-031-36678-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-36678-9_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-36677-2

  • Online ISBN: 978-3-031-36678-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics